Oral chemotherapy drug development has significantly increased during the past several years and is anticipated to continue to grow. A new generation of targeted therapies, many of them taken orally, have transformed cancer treatment for many patients. This presentation will address the challenges associated with oral treatment regimens for cancer patients.

This educational activity consists of recorded presentations from the 2010 Advances in the Management of Oncology Patients conference held in Scottsdale, Arizona on April 26-28, 2010. For more information on additional presentations from this event please go to, http://www.optumhealtheducation.com/cme/oncology/advances-in-the-management-of-oncology-patients.

Learning Objectives
At the end of this educational activity, participants should be able to

1. Discuss how targeted therapies that are taken orally have impacted cancer treatment for cancer patients.
2. Outline challenges associated with oral treatment regimens for cancer patients.

Presenter
Sandhya Srinivas, MD
Associate Professor
Department of Medicine, Division of Oncology
Stanford Cancer Center
Stanford, California

Faculty Disclosures
As a sponsor accredited by the ACCME, the Institute for the Advancement of Human Behavior and the joint sponsor, OptumHealth Education requires the disclosure of any significant financial interest or other relationship a faculty member or sponsor has with the manufacturer(s) of any product discussed in this educational presentation. The faculty reported the following:

Sandhya Srinivas, MD
Dr Srinivas has indicated that he has no relevant financial relationships.
Dr Srinivas does not intend to discuss unapproved/investigative use of commercial products/devices.

Disclosure of Unlabeled or Investigational Drugs
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Staff Disclosures
In compliance with the ACCME's Standards for Commercial Support, employees of OptumHealth Education who have control over content of a CME activity are required to disclose their relevant financial relationships. No employee has a relevant financial relationship regarding this activity.

Contact Information for Content, Website and/or CNE/CE Questions
OptumHealth Education
Phone: (800) 326-9166
E-mail: [email protected]

Contact Information for CME Credit Questions
Sheryl Morgan
Institute for the Advancement of Human Behavior
Phone: (651) 789-3730
E-mail: [email protected]

Instructions for Participation and Credit
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

To participate in this activity, begin by viewing the CE Info and then follow the prompts.

Sponsored By
This activity is jointly sponsored by the Institute for the Advancement of Human Behavior and OptumHealth Education.

Commercial Support
There was no commercial support received for this activity.

Hardware/Software Requirements
To view this Webcast you will need Internet Explorer 7.0+ or Firefox 3.0+ with Windows Media Player 9+, RealPlayer 12+, or Adobe Flash Player 9+. Be sure to disable your pop-up blocking software.

Please see our Privacy Policy by clicking here